Introduction
Angiotensin II is an octapeptide known to affect the cardiovascular system by increasing blood pressure. Although its effect was largely studied at the vascular smooth muscle and renal levels, fewer studies were done in vascular endothelial cells. This octapeptide is known to regulate the function of VECs (Stoll et al. 1995a) . It is also known to be implicated in proliferation (Stoll et al. 1995) and survival (Dimmeler et al. 1997; Rossig et al. 2002) of VECs. Studies showed that AngII modulates intracellular calcium of human umbilical vein endothelial cells (Ko et al. 1997) . However, no studies were done in normal adult VECs and in particular of human origin. Several studies in vascular smooth muscle cells including those of human origin (hVSMCs) showed the presence of AT 1 R at the plasma membrane (PM), however, that of AT 2 R was limited to the nuclear membranes level (Bkaily et al. 2003) . Furthermore, in hVSMCs, plasma membrane as well nuclear membranes AT 1 Rs were shown to undergo internalization and nuclear translocation (Bkaily at al., 2003) . However, it is not yet known whether such a phenomenon takes place in hVECs. Internalization of AT 1 R is highly important since it is implicated in the sustained activation of signaling induced by this type of receptor (Schelling and Linas 1994) . In addition, internalization of this receptor contributes to the regulation of the density of the receptor (Hein et al. 1997) as well as the accumulation of AngII inside the cell (Booz et al. 1992; Bkaily et al. 2009 Bkaily et al. , 2012 ) which contributes to nuclear membrane AngII receptors activation (Booz et al. 1992; Bkaily et al. 2009 Bkaily et al. , 2012 . In this study, we report that both AT 1 and AT 2 receptors are present in hVECs and that only AT 1 R undergoes internalization and nuclear translocation and modulates cytosolic and nuclear calcium.
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Materials and methods
Isolation and culture of hVECs.
hVECs were isolated from aortas of healthy donors (16-45 years old) supplied by Quebec Transplant. All work was done in accordance with the requirements of the institutional review committee for the use of human material. The freshly isolated and cultured hVECs used in this study originate from at least 5 different donors as previously described (Bkaily et al. 1997) . In brief, intact aortas, were placed for 15 min in M199 medium (Gibco-BRL, Burlington, ON) containing antibiotics and 0.1% (50 U/mL) collagenase. After that, the medium was replaced by a fresh, collagenase-free M199
solution containing antibiotics and hVECs were gently scraped with a sterile scalpel blade. The cell-containing medium was collected and centrifuged using the same conditions as those described previously (Bkaily et al. 1997; Avedanian et al. 2010) .
Cells were then cultured in M199 medium containing 10% fetal bovine serum and 50 IU/mL penicillin-G-potassium (Ayrest, Toronto, ON). A routine check of quality and purity of hVECs was done using specific probes (Bkaily et al. 1997; Avedanian et al. 2010) . Furthermore, functional quality control of cultured (used within 12 h of culture) and long-term cultured (passages 4-6) cells was routinely done (Bkaily et al. 1997; Avedanian et al. 2010) .
Indirect immunofluorescence
The protocol for indirect immunofluorescence was previously described (Bkaily et al. 2003) . Briefly, aortic hVECs were fixed with 4% paraformaldehyde followed by washing with PBS 1X and incubation for 10 min with PBS containing sodium borohydride (2 mg/mL). The cells were then permeabilized and blocked with 0.1% Triton X-100, 7% then examined using 3D imaging confocal microscopy. All antibodies were checked for specificity using a control peptide and no primary antibody and figure 1 shows examples.
Loading with the calcium fluorescent dye Fluo-3/AM.
The Ca 2+ fluorescence dye Fluo-3/AM (Molecular Probes, Eugene, OR) at a final concentration of 13 µM in Tyrode-BSA was used to load the cells as described previously (Bkaily et al. 1997 (Bkaily et al. , 1999 (Bkaily et al. , 2003 (Bkaily et al. , 2004 (Bkaily et al. , 2017 Ahmarani et al. 2013) . In brief, hVECs were incubated with Fluo-3/AM for 1 hour at room temperature, washed and then left for 15 min to ensure complete hydrolysis of the acetoxymethyl ester groups before starting the experiments. Fluo-3 was found to be homogeneously distributed all through the cells (Bkaily et al. 2001 (Bkaily et al. , 2003 and was calibrated to be expressed in absolute concentration of free Ca 2+ (Bkaily et al. 2001 ).
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Confocal microscopy, volume rendering and quantitative fluorescence intensity measurement.
Cells were examined with a Multiprobe 2001 confocal krypton-argon laser scanning system (Molecular Dynamics, Sunnyvale, CA) or a Bio-Rad confocal krypton-argon and ultraviolet laser system as previously described (Bkaily et al. 1997 (Bkaily et al. , 2004 (Bkaily et al. , 2017 Ahmarani et al. 2013) . In brief, laser line intensity, photometric gain, PMT settings, and filter attenuation were kept rigorously constant throughout the experimental procedures (Bkaily et al. 1997 (Bkaily et al. , 1999 (Bkaily et al. , 2017 . At the end of each experiment, the nucleus was stained with 100 nmol/L of live cell nucleic acid stain SYTO-11 (Molecular Probes, Eugene, OR) as described previously (Bkaily et al. 1997 (Bkaily et al. , 2017 projections (not deconvolution) (Bkaily et al. 2017) .
Western blot
Extraction of proteins to be used for Western blot was performed using the same protocol described elsewehere (Bkaily et al. 2003) In the first series of experiments we used specific antibodies directed against AngII. Figure 1A -B shows an example and figure 2A summarizes the results. As seen in these figures, AngII was present all through the cell including the nucleus. It was distributed in a heterogeneous manner and its relative density was significantly (p<0.001) lower in the nucleus (including the perinucleoplasmic envelope) compared to the cytosol.
In another series of experiments, we determined the presence, distribution and relative density of AT 1 R in hVECs. Figure 1G shows an example and figure 2B summarizes the results. These figures show the presence of AT 1 R at the PM, cytosol, NEMs as well as nucleoplasm. It was heterogeneously distributed throughout the cell including the nucleus ( Fig. 1G ) and its relative density is higher (p<0.001) in the nucleus (including NEMs) than in the cytosol (Fig. 2B ). Its relative density was near six-fold higher in the nucleus compared to the cytosol.
In the last series of experiments, we determined the presence, distribution and relative density of AT 2 R in hVECs. Figure 1M shows an example and figure 2C summarizes the results. As seen in these figures, AT 2 R was mainly present at the PM with a lower level in the cytosol. Its distribution in the nucleus seemed to be relatively homogeneous including the NEMs. Its relative density at the nuclear level (including NEMs) was nearly double that in the cytosol (including PM) (p<0.001) (Fig. 2C ).
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Role of AT 1 R and AT 2 R in AngII-induced increase of cytosolic and nuclear free calcium.
In this series of experiments, we tested the effect of different concentrations of AngII (10 -15 -10 -5 M) on cytosolic and nuclear calcium in hVECs. Figure 3 A-K show examples and figure 3 M summarizes the results. As expected, the nuclear level of calcium was higher than that in the cytosol in control condition ( Fig. 3A) and this difference was maintained at all concentrations of AngII used. As seen in figure 3A -K, increasing the concentration of AngII induced an increase of cytosolic and nuclear calcium. Figure 3M shows the concentration-dependent effect of AngII on cytosolic and nuclear calcium. As can be seen, the maximum effect of AngII took place at a concentration of 10 -10 M (cytosolic calcium) to 10 -9 M (nuclear calcium) and then a plateau was reached. The concentration of 10 -9 M was used in all the subsequent protocols in order to produce a maximal effect on the increase of cytosolic and nuclear calcium indiuced by AngII. The calculated EC 50 was similar for cytosolic and nuclear calcium (4.3x10 -14 M and 6.3x10 -14 M respectively).
In the next series of experiments, we tested the effect of AT 1 R specific antagonist, losartan (10 -6 M) on AngII (10 -9 M) induced increase of cytosolic and nuclear calcium.
The concentration of losartan used was reported to completely block AT 1 R (Bkaily et al. 2003; Jacques et al. 2003 ). Figure 4 A shows examples and figure 4 B summarizes the results. Superfusion for 5 min with losartan had no effect on cytosolic and nuclear calcium. In the presence of the AT 1 R antagonist, superfusion with a concentration of AngII (10 -9 M) that induces a maximum effect on intracellular calcium had no effect on cytosolic and nuclear calcium ( Figure 4 A and B). However, washout with a solution free D r a f t of losartan but containing 10 -9 M of AngII induced, within a minute, a significant increase of cytosolic and nuclear calcium (p<0.001).
In the last series of experiments, we verified whether the effect of AngII on intracellular calcium is also mediated via activation of AT 2 R. Figure 5 A shows examples and figure 5 B summarizes the results. As seen in this figure, the presence of the AT 2 R specific receptor antagonist, PD123319 (10 -6 M), did not prevent AngII (10 -9 M) from inducing a significant (p<0.001) increase of cytosolic and nuclear calcium.
Effect of AngII on AT 1 R and AT 2 R trafficking and levels in hVECs.
In this series of experiments, we tested the effect of a high concentration of AngII (10 -10 M) on AT 2 R trafficking and its relative cytosolic (including PM) and nuclear (including NEM) levels. As seen in figure 6 A and B, AngII had no effect on cytosolic and nuclear levels of AT 2 R. Pretreatment with PD123319 and stimulation with AngII (10 -10 M) did not affect the distribution and the relative level of AT 2 R all through the cells (Fig. 6 ).
In the next series of experiments, we used the same protocol as for AT 2 R in order to verify whether AT 1 R undergoes internalization upon activation by AngII. As seen in figure 7 A and B, AngII did not affect the distribution and level of AT 1 R during the first 15 min of exposure to the octapeptide. However, at 30 min, there was a decrease of both cytosolic (p<0.01) and nuclear (p<0.001) AT 1 R levels. At 60 min, the distribution and cytosolic and nuclear levels of AT 1 R return back to the normal level. Blockade of AT 1 R prevented AngII from inducing a transient decrease of cytosolic and nuclear levels of AT 1 R ( Fig. 7 A and B ).
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In the following series of experiments, we verified whether blockade of protein synthesis with cycloheximide (10 µg/mL) would prevent the re-increase of AT 1 R level induced by AngII at 60 min. As seen in figure 8, treatment for 30min with cycloheximide decreased (p<0.01) the level of cytosolic and nuclear AT 1 R levels. In the presence of cycloheximide, treatment with AngII (10 -10 M) had no effect on the distribution and relative levels of AT 1 R during the first 15 min. However, further decrease took place at 30 min at both the cytosolic and nuclear levels. This decrease persisted as long as cycloheximide is present (Fig. 8 ).
In the last series of experiments, using Western blot and the protocol described above, we wanted to confirm the effect of 60-min exposure to AngII (10 -10 M) on the relative density AT 1 R observed using quantitative 3D confocal microscopy. Figure 9 shows examples. As can be seen in figure 9 A, at 30 min, AngII induced a decrease in the relative total AT 1 R protein followed by de novo synthesis. This de novo synthesis was prevented by the protein synthesis inhibitor cycloheximide ( Fig. 9 A and B) . In addition, the AT 1 R inhibitor losartan but not the AT 2 R inhibitor PD123319 prevented the decrease of the protein level of AT 1 R at 30 min (Figure 9 A).
Discussion
In this study, contrary to what was reported previously in human aortic smooth muscle cells (Bkaily et al. 2003 (Bkaily et al. , 2009 (Bkaily et al. , 2012 , our results show that, in human aortic endothelial cells (hVECs), both AT 1 R and AT 2 R are present at the cytosolic (including PM) and nuclear (including NEM) levels. However, our results are similar to those reported in human endocardial endothelial cells (hEECs) (Jacques et al. 2003) . In addition, AngII is found to be present at both the cytosolic and nuclear levels. The octapeptide and both its receptors are distributed heterogeneously all through hVECs. Contrary to hEECs (Jacques et al. 2003) , the level of AngII is significantly higher in the cytosol compared to the nucleus. However, similar to hEECs (Jacques et al. 2003) , the relative density of AT 1 R and AT 2 R in hVECs is higher in the nucleus (including NEM) compared to the cytosol (including PM). The presence of AngII at the cytosolic and nucleoplasmic levels will promote activation of its receptors at the nuclear level thus modulating nucleoplasmic calcium homeostasis and gene expression (Bkaily et al. 2003 (Bkaily et al. , 2009 (Bkaily et al. , 2014 (Bkaily et al. , 2017 . Our results also show that, as in hEECs (Jacques et al. 2003) and hVSMCs (Bkaily et al. 2003 (Bkaily et al. , 2009 (Bkaily et al. , 2014 , AngII induces a dose-dependent sustained increase of cytosolic and nuclear calcium. However, its EC 50 value is lower in hVECs (near 10 (Bkaily et al. 2003) . This difference in EC 50 between hVECs, hEECs (Jacques et al.
2003
) and hVSMCs (Bkaily et al. 2003) could be due to the higher density of AT 1 R in hVECs at both the cytosolic (including PM) and nuclear (including NEM) levels. This is supported by the fact that the absence of AT 1 R at the nuclear membranes level of hVSMCs is associated with a high EC 50 value (Bkaily et al. 2003 ) when compared to D r a f t hVECs and that a low expression of human AT 1 R increases the EC 50 value of AngII in hVSMCs (Bkaily et al. 2003) . These results suggest that hVECs are highly sensitive to AT 2 R and this is followed, at 30 minutes, by degradation of the receptor and then by de novo synthesis taking place at 60 minutes. This de novo synthesis is supported by the fact that it is sensitive to the protein synthesis inhibitor cycloheximide. Interestingly, the decrease in the relative density of cytosolic and nuclear AT 1 R (not AT 2 R) is prevented by the AT 1 R antagonist losartan. These results suggest that the AT 1 R antagonist does not by itself promote internalization of its receptor but prevents it from being internalized by inhibiting AngII binding. It is possible that internalization of a receptor upon its binding to its ligand will contribute to its biological effects. This action of the internalized receptor/ligand complex can, in part, make available the ligand in the cytosol in order to activate its receptors at the NEMs (Bkaily et al. 2003 (Bkaily et al. , 2012 (Bkaily et al. , 2014 . In addition, it is also possible that the internalized phosphorylated receptor/ligand complex will continue its signaling and effects at both the cytosolic and nucleoplasmic levels. This needs to be explored. 138x161mm (300 x 300 DPI)
D
